Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07039435 · ClinicalTrials.gov registry record · NA
Perceptual Adaptation Following Cochlear Implantation (Aim 3a)
A NA study of Sensorineural Hearing Loss and Cochlear Implantation, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT07039435: Recruiting NA study of Sensorineural Hearing Loss and Cochlear Implantation, sponsored by NYU Langone Health.
NCT07039435 is a NA study of Sensorineural Hearing Loss and Cochlear Implantation that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 22 participants, below the 129-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07039435, a NA study of Sensorineural Hearing Loss and Cochlear Implantation, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to study the adaptation process in newly implanted Single-Sided Deaf Cochlear Implant (SSD-CI) users. Subjects will use four frequency maps for the first month after CI activation. One of these maps will be standard of care and the other three will have higher low frequency edges than the standard of care default maps. These maps will alternate daily during the first month (with exceptions made for situations when the subject is allowed to use a preferred map rather than the map predetermined for use that day), and after that point each subject will make a selection at the beginning of the week to compare all four maps and decide which one to use at the beginning of the following week. The goal of this study is to investigate how reducing place-pitch mismatch in SSD CI users affects 1) sound quality, 2) device use, and 3) speech perception.
Primary Outcome
The BKB-SIN speech-in-noise test measures speech perception in noise by assessing a listener's signal-to-noise ratio (SNR) loss. The test results are presented as the SNR loss, which is the amount the signal-to-noise ratio needs to be increased for the listener to correctly repeat 50% of the sentences. A higher SNR loss indicates more difficulty hearing.
Conditions Studied
Interventions
- OTHER Alternative Frequency Mapping
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2024-01-04 |
| Est. Completion | 2029-07-31 |
| Phase | NA |
What NCT07039435 shows while recruiting
NCT07039435 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 129-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (83% lower).
The record links to 3 conditions, with Sensorineural Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which Alternative Frequency Mapping is the first listed.
NCT07039435 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07039435 about?
NCT07039435 is a clinical study titled "Perceptual Adaptation Following Cochlear Implantation (Aim 3a)". The goal of this study is to study the adaptation process in newly implanted Single-Sided Deaf Cochlear Implant (SSD-CI) users. Subjects will use four frequency maps for the first month after CI activation. One of these maps will be standard of care and the other three will have higher low frequency...
What is the current status of trial NCT07039435?
This trial is currently recruiting. It is a NA study. The enrollment target is 22 participants. The study started on 2024-01-04. Estimated completion is 2029-07-31.
What conditions does trial NCT07039435 study?
This clinical trial studies the following conditions: Sensorineural Hearing Loss, Cochlear Implantation, Perceptual Adaptation.
What interventions are being tested in trial NCT07039435?
The interventions under investigation include: Alternative Frequency Mapping (OTHER).
Who is sponsoring clinical trial NCT07039435?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07039435 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sensorineural Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07039435's enrollment target sits among peer trials
22 11th of 13 higher than 3 of 13 other Sensorineural Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sensorineural Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Clear Speech on Listening Effort and Memory in Sentence Processing
RECRUITING · NA
-
Social Influences on Sensorimotor Integration of Speech Production and Perception During Early Vocal Learning
RECRUITING · NA
-
Pivotal Clinical Trial Evaluating the Safety and Efficacy of the Fully Implanted Acclaim Cochlear Implant
ACTIVE NOT RECRUITING · NA
-
The Effect of Sound Stimulation on Pure-tone Hearing Threshold
COMPLETED · NA
-
Evaluation of the Nucleus Hybrid™ L24 Cochlear Implant System
COMPLETED · NA
-
Perimodiolar Implant Performance in Adults With Low-Frequency Residual Hearing
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI